These data, together with the well-documented role of abnormal SOD1 in neuronal death in rare genetic forms of ALS, suggest that disSOD1 pathology may constitute a valuable new disease target for slowing the progression of Parkinson disease. The gene discussed is SOD1; the disease is Parkinson disease.